Clinical efficacy and safety of a novel antiretroviral drug for HIV infection Oct. 7, 2014 No Comments
Clinical results presented for the novel cell-based anti-HIV therapy, SB-728-T Oct. 6, 2014 No Comments
EMA committee recommends approval of Rezolsta, announces darunavir label extensions Sep. 30, 2014 No Comments
Gilead reports phase III data for elvitegravir/cobicistat/tenofovir alafenamide/emtricitabine Sep. 26, 2014 No Comments
RSS